EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Assessing environmental enteric dysfunction via multiplex assay and its relation to growth and development among HIV-exposed uninfected Tanzanian infants

Jacqueline M Lauer iD, Miles A Kirby, Alfa Muhihi, Nzovu Ulenga, Said Aboud, Enju Liu, Robert K M Choy, Michael B Arndt, Jianqun Kou, Wafaie Fawzi, Andrew Gewirtz, Christopher R Sudfeld und 2 weitere

PLOS Neglected Tropical Diseases · 2023

DOI: 10.1371/journal.pntd.0011181 ↗

Kurz gefasst

Fachartikel in der Zeitschrift PLOS Neglected Tropical Diseases, 2023. Verfasst von Jacqueline M Lauer und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of Health Sciences, College of Health & Rehabilitation Sciences: Sargent College, Boston University, Boston, Massachusetts, United States …. Hauptthemen laut MEDLINE: Lipopolysaccharide Receptors, HIV Infections. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 30 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIDDK NIH HHS, NICHD NIH HHS, National Institute of Child Health and Human Development.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Environmental enteric dysfunction (EED) may contribute to poor growth and development in young children. While validated EED biomarkers are currently lacking, multiplex assays are able to capture multiple domains of the condition. The purpose of this exploratory study was to examine the relationship between biomarkers of EED and subsequent growth and development among Tanzanian HIV-exposed uninfected (HEU) infants. Methodology We enrolled 467 infants of mothers living with HIV who had participated in a trial of vitamin D 3 supplementation during pregnancy. Infant serum samples collected at 6 weeks (n = 365) and 6 months (n = 266) were analyzed for anti-flagellin and anti-lipopolysaccharide (LPS) IgA and IgG via ELISA as well as the 11-plex Micronutrient and EED Assessment Tool (MEEDAT), which incorporates two biomarkers of EED [intestinal fatty acid-binding protein (I-FABP) and soluble CD14 (sCD14)]. Outcomes were 12-month growth [length-for-age z-score (LAZ), weight-for-length z-score (WLZ), and weight-for-age z-score (WAZ)] and development [Caregiver Reported Early Development Instruments (CREDI) z-scores] and were assessed using linear regression.

Findings

In primary analyses, higher quartiles of 6-month anti-LPS IgG concentrations were significantly associated with lower LAZ at 12 months (p trend = 0.040). In secondary analyses, higher log 2 -transformed 6-week anti-flagellin IgA and 6-month anti-LPS IgA concentrations were significantly associated with lower LAZ at 12 months. No associations were observed between I-FABP or sCD14 and infant growth. However, higher log 2 -transformed 6-week sCD14 concentrations were significantly associated with lower overall CREDI z-scores, while higher log 2 -transformed 6-month I-FABP concentrations were significantly associated with higher overall CREDI z-scores.

Conclusions

Unlike anti-flagellin and anti-LPS Igs, MEEDAT’s biomarkers of EED (I-FABP and sCD14) were not associated with subsequent linear growth among HEU infants in Tanzania. The relationship between EED and infant development warrants further study.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Lipopolysaccharide ReceptorsHIV InfectionsPregnancyFemaleChildHumansInfantChild, PreschoolTanzaniaChild DevelopmentImmunoglobulin GImmunoglobulin A

Substanzen

Lipopolysaccharide ReceptorsImmunoglobulin GImmunoglobulin A

Autor:innen und Institutionen

  • Department of Health Sciences, College of Health & Rehabilitation Sciences: Sargent College, Boston University, Boston, Massachusetts, United States of America.
  • Department of Global Health and Population, Harvard T.H. Chan School of Public Health, Boston, Massachusetts, United States of America.
  • Management and Development for Health, Dar es Salaam, Tanzania.
  • Department of Microbiology and Immunology, Muhimbili University of Health and Allied Sciences, Dar es Salaam, Tanzania.
  • Division of Gastroenterology, Hepatology and Nutrition, Boston Children's Hospital, Boston, Massachusetts, United States of America.
  • Institutional Centers for Clinical and Translational Research, Boston Children's Hospital, Boston, Massachusetts, United States of America.

ORCID-Profile: Jacqueline M Lauer

Förderung

  • NIDDK NIH HHS
  • NICHD NIH HHS
  • National Institute of Child Health and Human Development
  • National Institute of Diabetes and Digestive and Kidney Diseases

Zitieren

APA

Lauer, J. M., Kirby, M. A., Muhihi, A., Ulenga, N., Aboud, S., Liu, E., Choy, R. K. M., Arndt, M. B., Kou, J., Fawzi, W., Gewirtz, A., Sudfeld, C. R., Manji, K. P., & Duggan, C. P. (2023). Assessing environmental enteric dysfunction via multiplex assay and its relation to growth and development among HIV-exposed uninfected Tanzanian infants. PLOS Neglected Tropical Diseases. https://doi.org/10.1371/journal.pntd.0011181

Vancouver

Lauer JM, Kirby MA, Muhihi A, Ulenga N, Aboud S, Liu E, et al. Assessing environmental enteric dysfunction via multiplex assay and its relation to growth and development among HIV-exposed uninfected Tanzanian infants. PLOS Neglected Tropical Diseases. 2023. doi:10.1371/journal.pntd.0011181

BibTeX
@article{Lauer2023,
  author = {Lauer, Jacqueline M and Kirby, Miles A and Muhihi, Alfa and Ulenga, Nzovu and Aboud, Said and Liu, Enju and Choy, Robert K M and Arndt, Michael B and Kou, Jianqun and Fawzi, Wafaie and Gewirtz, Andrew and Sudfeld, Christopher R and Manji, Karim P and Duggan, Christopher P},
  title = {Assessing environmental enteric dysfunction via multiplex assay and its relation to growth and development among HIV-exposed uninfected Tanzanian infants},
  journal = {PLOS Neglected Tropical Diseases},
  year = {2023},
  doi = {10.1371/journal.pntd.0011181}
}
Kostenlos starten →